Clinical Nutrition For Cancer Care Market
Clinical Nutrition For Cancer Care Market Forecasts to 2030 - Global Analysis By Product (Parenteral Nutrition, Oral Nutrition, Enteral Feeding Formulas and Other Products), Sales Channel (Institutional Sales, Retail, Online and Other Sales Channels) and By Geography
According to Stratistics MRC, the Global Clinical Nutrition For Cancer Care Market is accounted for $6.026 billion in 2023 and is expected to reach $9.702 billion by 2030 growing at a CAGR of 7.0% during the forecast period. Clinical nutrition for cancer care refers to the specialized field within healthcare that focuses on providing tailored nutritional support to individuals diagnosed with cancer. From managing side effects of treatments such as chemotherapy and radiation therapy to supporting overall nutritional status and immune function, clinical nutrition plays a crucial role in optimizing outcomes and quality of life for cancer patients.
According to the CDC, approximately 58% of cancer cases are found in adults aged 65 years or older. According to the American Association for Cancer Research Progress Report 2023, the overall U.S. cancer mortality rates have seen a decline, owing to the steady downfall of mortality rates from breast, colon, rectum, lung, and prostate cancers.
Market Dynamics:
Driver:
Increasing cancer prevalence
As cancer rates continue to rise due to factors such as aging populations, lifestyle changes, and environmental factors, the demand for effective nutritional support during cancer treatment becomes more pronounced. Clinical nutrition plays a crucial role in supporting cancer patients by addressing their unique nutritional needs, which can be compromised due to the disease itself or its treatments such as chemotherapy and radiation therapy. Tailored nutrition plans can help manage symptoms, maintain strength and energy levels, optimize treatment outcomes, and enhance overall quality of life for cancer patients.
Restraint:
Complexity of cancer treatment
Cancer treatment often involves a multifaceted approach, including surgery, chemotherapy, radiation therapy, immunotherapy, and targeted therapy. Each of these treatments can affect the patient's nutritional needs differently, leading to challenges in developing tailored nutrition plans. Cancer patients frequently experience side effects such as nausea, vomiting, loss of appetite, and difficulty swallowing, which can further complicate their ability to maintain adequate nutrition. As a result, healthcare providers must navigate a complex landscape to ensure that patients receive appropriate nutrition support that addresses their unique treatment regimens and symptoms.
Opportunity:
Rising geriatric population
As individuals age, their susceptibility to various illnesses, including cancer, rises. Elderly individuals often face challenges such as decreased appetite, difficulty swallowing, and compromised nutrient absorption, which can exacerbate the effects of cancer and its treatment. Consequently, there is a growing demand for specialized clinical nutrition solutions tailored to the unique needs of cancer patients, particularly among the elderly demographic. These nutritional interventions are designed to provide essential nutrients, manage treatment side effects, maintain muscle mass, and support overall health and quality of life during cancer therapy.
Threat:
High cost
Cancer treatment itself is financially burdensome, and adding the expense of specialized nutritional support further exacerbates the financial strain on patients and healthcare systems. The cost encompasses not only the nutritional products themselves but also the expertise required for personalized dietary planning, monitoring, and adjustments based on individual patient needs. However, the development and manufacturing of specialized nutritional formulations tailored to cancer patients often involve intricate processes and high-quality ingredients, further driving up costs.
Covid-19 Impact:
The pandemic disrupted supply chains, causing shortages in essential nutrients and supplements crucial for cancer patients undergoing treatment. Access to specialized clinical nutrition services was also hampered due to restrictions on movement and healthcare facility closures, leading to delays in treatment and management of cancer-related malnutrition. The focus of healthcare systems shifted towards managing COVID-19 cases, diverting resources away from cancer care services and research.
The Parenteral Nutrition segment is expected to be the largest during the forecast period
Parenteral Nutrition segment is expected to be the largest during the forecast period due to its ability to provide essential nutrients directly into the bloodstream, bypassing the digestive system. This method is particularly crucial for cancer patients who may have compromised digestive function due to the disease or its treatment, such as surgery, chemotherapy, or radiation therapy. Parenteral nutrition ensures that patients receive adequate nutrition despite difficulties with oral intake, enabling them to maintain their strength and better tolerate aggressive cancer treatments.
The Institutional Sales segment is expected to have the highest CAGR during the forecast period
Institutional Sales segment is expected to have the highest CAGR during the forecast period. Institutions such as hospitals, cancer treatment centers, and long-term care facilities are increasingly recognizing the importance of personalized nutrition plans in cancer patient management. With rising incidences of cancer worldwide, there's a growing demand for specialized clinical nutrition solutions tailored to the unique needs of cancer patients. Furthermore, institutional sales channels provide access to a large network of healthcare facilities, enabling the distribution of these specialized nutritional products efficiently.
Region with largest share:
Because of its growing population, high out-of-pocket healthcare spending, and fast increasing purchasing power to access a variety of technologically advanced healthcare services, severe poverty, and lack of nutritional awareness, the Asia Pacific region held the largest share of the market over the projection period. Furthermore, preventive care utilization for elderly, pediatric, and long-term care patients is anticipated to rise as a result of increased government initiatives pertaining to technology improvements and balancing effective regulatory compliance needs.
Region with highest CAGR:
Asia Pacific region is poised to witness profitable growth over the extrapolated period. In India, clinical nutrition plays a crucial role in helping patients receiving cancer treatment adapt to new diets. The industry has grown considerably as a result of the regional expansion of major international firms, including RPG Life Sciences, Hexagon Nutrition Limited, Ajanta Pharma Limited, and Nutricia Limited. In addition, increased market penetration of these products in India and rising per capita healthcare spending are some of the factors anticipated to drive market growth in the upcoming years.
Key players in the market
Some of the key players in Clinical Nutrition For Cancer Care market include Abbott Nutrition, Baxter International Inc, Bayer AG, Celgene Corporation, Danone Nutricia, GlaxoSmithKline plc, Kyowa Hakko Kirin Co., Ltd, Mead Johnson & Company, LLC, Novartis AG, Otsuka Holdings Co., Ltd, Pfizer Inc, Roche Holding AG and Teva Pharmaceutical Industries Ltd.
Key Developments:
In January 2024, Danone partnered with digital oncology company Resilience to create a nutrition and oncology module integrated within Resilience's digital oncology solution. This module aims to address cancer-related malnutrition, which impacts approximately 70% of cancer patients.
In November 2023, Danone introduced the Fortimel product range—their first medical nutrition product in the adult Foods for Special Medical Purposes (FSMP) category—in response to rising chronic disease and an aging population in China.
In January 2023, Nestlé India expanded its Health Science portfolio by launching ThickenUp Clear, a food and beverage thickener for patients with swallowing difficulties, aiding those with dysphagia due to conditions like head and neck cancer, stroke, and Parkinson’s Disease.
Products Covered:
• Parenteral Nutrition
• Oral Nutrition
• Enteral Feeding Formulas
• Other Products
Sales Channels Covered:
• Institutional Sales
• Retail
• Online
• Other Sales Channels
Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Table of Contents
1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 Emerging Markets
3.8 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Clinical Nutrition For Cancer Care Market, By Product
5.1 Introduction
5.2 Parenteral Nutrition
5.3 Oral Nutrition
5.4 Enteral Feeding Formulas
5.5 Other Products
6 Global Clinical Nutrition For Cancer Care Market, By Sales Channel
6.1 Introduction
6.2 Institutional Sales
6.3 Retail
6.4 Online
6.5 Other Sales Channels
7 Global Clinical Nutrition For Cancer Care Market, By Geography
7.1 Introduction
7.2 North America
7.2.1 US
7.2.2 Canada
7.2.3 Mexico
7.3 Europe
7.3.1 Germany
7.3.2 UK
7.3.3 Italy
7.3.4 France
7.3.5 Spain
7.3.6 Rest of Europe
7.4 Asia Pacific
7.4.1 Japan
7.4.2 China
7.4.3 India
7.4.4 Australia
7.4.5 New Zealand
7.4.6 South Korea
7.4.7 Rest of Asia Pacific
7.5 South America
7.5.1 Argentina
7.5.2 Brazil
7.5.3 Chile
7.5.4 Rest of South America
7.6 Middle East & Africa
7.6.1 Saudi Arabia
7.6.2 UAE
7.6.3 Qatar
7.6.4 South Africa
7.6.5 Rest of Middle East & Africa
8 Key Developments
8.1 Agreements, Partnerships, Collaborations and Joint Ventures
8.2 Acquisitions & Mergers
8.3 New Product Launch
8.4 Expansions
8.5 Other Key Strategies
9 Company Profiling
9.1 Abbott Nutrition
9.2 Baxter International Inc
9.3 Bayer AG
9.4 Celgene Corporation
9.5 Danone Nutricia
9.6 GlaxoSmithKline plc
9.7 Kyowa Hakko Kirin Co., Ltd
9.8 Mead Johnson & Company, LLC
9.9 Novartis AG
9.10 Otsuka Holdings Co., Ltd
9.11 Pfizer Inc
9.12 Roche Holding AG
9.13 Teva Pharmaceutical Industries Ltd
List of Tables
1 Global Clinical Nutrition For Cancer Care Market Outlook, By Region (2021-2030) ($MN)
2 Global Clinical Nutrition For Cancer Care Market Outlook, By Product (2021-2030) ($MN)
3 Global Clinical Nutrition For Cancer Care Market Outlook, By Parenteral Nutrition (2021-2030) ($MN)
4 Global Clinical Nutrition For Cancer Care Market Outlook, By Oral Nutrition (2021-2030) ($MN)
5 Global Clinical Nutrition For Cancer Care Market Outlook, By Enteral Feeding Formulas (2021-2030) ($MN)
6 Global Clinical Nutrition For Cancer Care Market Outlook, By Other Products (2021-2030) ($MN)
7 Global Clinical Nutrition For Cancer Care Market Outlook, By Sales Channel (2021-2030) ($MN)
8 Global Clinical Nutrition For Cancer Care Market Outlook, By Institutional Sales (2021-2030) ($MN)
9 Global Clinical Nutrition For Cancer Care Market Outlook, By Retail (2021-2030) ($MN)
10 Global Clinical Nutrition For Cancer Care Market Outlook, By Online (2021-2030) ($MN)
11 Global Clinical Nutrition For Cancer Care Market Outlook, By Other Sales Channels (2021-2030) ($MN)
12 North America Clinical Nutrition For Cancer Care Market Outlook, By Country (2021-2030) ($MN)
13 North America Clinical Nutrition For Cancer Care Market Outlook, By Product (2021-2030) ($MN)
14 North America Clinical Nutrition For Cancer Care Market Outlook, By Parenteral Nutrition (2021-2030) ($MN)
15 North America Clinical Nutrition For Cancer Care Market Outlook, By Oral Nutrition (2021-2030) ($MN)
16 North America Clinical Nutrition For Cancer Care Market Outlook, By Enteral Feeding Formulas (2021-2030) ($MN)
17 North America Clinical Nutrition For Cancer Care Market Outlook, By Other Products (2021-2030) ($MN)
18 North America Clinical Nutrition For Cancer Care Market Outlook, By Sales Channel (2021-2030) ($MN)
19 North America Clinical Nutrition For Cancer Care Market Outlook, By Institutional Sales (2021-2030) ($MN)
20 North America Clinical Nutrition For Cancer Care Market Outlook, By Retail (2021-2030) ($MN)
21 North America Clinical Nutrition For Cancer Care Market Outlook, By Online (2021-2030) ($MN)
22 North America Clinical Nutrition For Cancer Care Market Outlook, By Other Sales Channels (2021-2030) ($MN)
23 Europe Clinical Nutrition For Cancer Care Market Outlook, By Country (2021-2030) ($MN)
24 Europe Clinical Nutrition For Cancer Care Market Outlook, By Product (2021-2030) ($MN)
25 Europe Clinical Nutrition For Cancer Care Market Outlook, By Parenteral Nutrition (2021-2030) ($MN)
26 Europe Clinical Nutrition For Cancer Care Market Outlook, By Oral Nutrition (2021-2030) ($MN)
27 Europe Clinical Nutrition For Cancer Care Market Outlook, By Enteral Feeding Formulas (2021-2030) ($MN)
28 Europe Clinical Nutrition For Cancer Care Market Outlook, By Other Products (2021-2030) ($MN)
29 Europe Clinical Nutrition For Cancer Care Market Outlook, By Sales Channel (2021-2030) ($MN)
30 Europe Clinical Nutrition For Cancer Care Market Outlook, By Institutional Sales (2021-2030) ($MN)
31 Europe Clinical Nutrition For Cancer Care Market Outlook, By Retail (2021-2030) ($MN)
32 Europe Clinical Nutrition For Cancer Care Market Outlook, By Online (2021-2030) ($MN)
33 Europe Clinical Nutrition For Cancer Care Market Outlook, By Other Sales Channels (2021-2030) ($MN)
34 Asia Pacific Clinical Nutrition For Cancer Care Market Outlook, By Country (2021-2030) ($MN)
35 Asia Pacific Clinical Nutrition For Cancer Care Market Outlook, By Product (2021-2030) ($MN)
36 Asia Pacific Clinical Nutrition For Cancer Care Market Outlook, By Parenteral Nutrition (2021-2030) ($MN)
37 Asia Pacific Clinical Nutrition For Cancer Care Market Outlook, By Oral Nutrition (2021-2030) ($MN)
38 Asia Pacific Clinical Nutrition For Cancer Care Market Outlook, By Enteral Feeding Formulas (2021-2030) ($MN)
39 Asia Pacific Clinical Nutrition For Cancer Care Market Outlook, By Other Products (2021-2030) ($MN)
40 Asia Pacific Clinical Nutrition For Cancer Care Market Outlook, By Sales Channel (2021-2030) ($MN)
41 Asia Pacific Clinical Nutrition For Cancer Care Market Outlook, By Institutional Sales (2021-2030) ($MN)
42 Asia Pacific Clinical Nutrition For Cancer Care Market Outlook, By Retail (2021-2030) ($MN)
43 Asia Pacific Clinical Nutrition For Cancer Care Market Outlook, By Online (2021-2030) ($MN)
44 Asia Pacific Clinical Nutrition For Cancer Care Market Outlook, By Other Sales Channels (2021-2030) ($MN)
45 South America Clinical Nutrition For Cancer Care Market Outlook, By Country (2021-2030) ($MN)
46 South America Clinical Nutrition For Cancer Care Market Outlook, By Product (2021-2030) ($MN)
47 South America Clinical Nutrition For Cancer Care Market Outlook, By Parenteral Nutrition (2021-2030) ($MN)
48 South America Clinical Nutrition For Cancer Care Market Outlook, By Oral Nutrition (2021-2030) ($MN)
49 South America Clinical Nutrition For Cancer Care Market Outlook, By Enteral Feeding Formulas (2021-2030) ($MN)
50 South America Clinical Nutrition For Cancer Care Market Outlook, By Other Products (2021-2030) ($MN)
51 South America Clinical Nutrition For Cancer Care Market Outlook, By Sales Channel (2021-2030) ($MN)
52 South America Clinical Nutrition For Cancer Care Market Outlook, By Institutional Sales (2021-2030) ($MN)
53 South America Clinical Nutrition For Cancer Care Market Outlook, By Retail (2021-2030) ($MN)
54 South America Clinical Nutrition For Cancer Care Market Outlook, By Online (2021-2030) ($MN)
55 South America Clinical Nutrition For Cancer Care Market Outlook, By Other Sales Channels (2021-2030) ($MN)
56 Middle East & Africa Clinical Nutrition For Cancer Care Market Outlook, By Country (2021-2030) ($MN)
57 Middle East & Africa Clinical Nutrition For Cancer Care Market Outlook, By Product (2021-2030) ($MN)
58 Middle East & Africa Clinical Nutrition For Cancer Care Market Outlook, By Parenteral Nutrition (2021-2030) ($MN)
59 Middle East & Africa Clinical Nutrition For Cancer Care Market Outlook, By Oral Nutrition (2021-2030) ($MN)
60 Middle East & Africa Clinical Nutrition For Cancer Care Market Outlook, By Enteral Feeding Formulas (2021-2030) ($MN)
61 Middle East & Africa Clinical Nutrition For Cancer Care Market Outlook, By Other Products (2021-2030) ($MN)
62 Middle East & Africa Clinical Nutrition For Cancer Care Market Outlook, By Sales Channel (2021-2030) ($MN)
63 Middle East & Africa Clinical Nutrition For Cancer Care Market Outlook, By Institutional Sales (2021-2030) ($MN)
64 Middle East & Africa Clinical Nutrition For Cancer Care Market Outlook, By Retail (2021-2030) ($MN)
65 Middle East & Africa Clinical Nutrition For Cancer Care Market Outlook, By Online (2021-2030) ($MN)
66 Middle East & Africa Clinical Nutrition For Cancer Care Market Outlook, By Other Sales Channels (2021-2030) ($MN)
List of Figures
RESEARCH METHODOLOGY
We at ‘Stratistics’ opt for an extensive research approach which involves data mining, data validation, and data analysis. The various research sources include in-house repository, secondary research, competitor’s sources, social media research, client internal data, and primary research.
Our team of analysts prefers the most reliable and authenticated data sources in order to perform the comprehensive literature search. With access to most of the authenticated data bases our team highly considers the best mix of information through various sources to obtain extensive and accurate analysis.
Each report takes an average time of a month and a team of 4 industry analysts. The time may vary depending on the scope and data availability of the desired market report. The various parameters used in the market assessment are standardized in order to enhance the data accuracy.
Data Mining
The data is collected from several authenticated, reliable, paid and unpaid sources and is filtered depending on the scope & objective of the research. Our reports repository acts as an added advantage in this procedure. Data gathering from the raw material suppliers, distributors and the manufacturers is performed on a regular basis, this helps in the comprehensive understanding of the products value chain. Apart from the above mentioned sources the data is also collected from the industry consultants to ensure the objective of the study is in the right direction.
Market trends such as technological advancements, regulatory affairs, market dynamics (Drivers, Restraints, Opportunities and Challenges) are obtained from scientific journals, market related national & international associations and organizations.
Data Analysis
From the data that is collected depending on the scope & objective of the research the data is subjected for the analysis. The critical steps that we follow for the data analysis include:
- Product Lifecycle Analysis
- Competitor analysis
- Risk analysis
- Porters Analysis
- PESTEL Analysis
- SWOT Analysis
The data engineering is performed by the core industry experts considering both the Marketing Mix Modeling and the Demand Forecasting. The marketing mix modeling makes use of multiple-regression techniques to predict the optimal mix of marketing variables. Regression factor is based on a number of variables and how they relate to an outcome such as sales or profits.
Data Validation
The data validation is performed by the exhaustive primary research from the expert interviews. This includes telephonic interviews, focus groups, face to face interviews, and questionnaires to validate our research from all aspects. The industry experts we approach come from the leading firms, involved in the supply chain ranging from the suppliers, distributors to the manufacturers and consumers so as to ensure an unbiased analysis.
We are in touch with more than 15,000 industry experts with the right mix of consultants, CEO's, presidents, vice presidents, managers, experts from both supply side and demand side, executives and so on.
The data validation involves the primary research from the industry experts belonging to:
- Leading Companies
- Suppliers & Distributors
- Manufacturers
- Consumers
- Industry/Strategic Consultants
Apart from the data validation the primary research also helps in performing the fill gap research, i.e. providing solutions for the unmet needs of the research which helps in enhancing the reports quality.
For more details about research methodology, kindly write to us at info@strategymrc.com
Frequently Asked Questions
In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.
Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.
All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
We have 3 different licensing options available in electronic format.
- Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
- 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
- Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.
All our reports are typically be emailed to you as an attachment.
To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.
We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.
Request Customization
We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.
WHY CHOOSE US ?
Assured Quality
Best in class reports with high standard of research integrity
24X7 Research Support
Continuous support to ensure the best customer experience.
Free Customization
Adding more values to your product of interest.
Safe & Secure Access
Providing a secured environment for all online transactions.
Trusted by 600+ Brands
Serving the most reputed brands across the world.
